Raymond Miller, JD

Ray Miller is a trusted intellectual property advisor to clients in a wide range of spaces. He adds value to each client's IP estate by providing clear and pragmatic guidance that allows for efficient navigation of IP opportunities. Ray helps clients identify, protect, secure and optimize the value of their IP. He advises on strategic patent prosecution, manufacturing and trade secret protection, and regulatory exclusivity strategies. Ray counsels materials science, pharmaceutical, medical device, biologics and digital therapeutics clients to allow them to obtain a sufficient return on their investment. Ray also manages freedom-to-operate, manufacturing and supply considerations on his clients' behalf. His clients include private equity and venture capital funds, pharmaceutical and biotechnology firms, world-class medical and research facilities, and Fortune 500 companies with well-developed intellectual property portfolios. Ray’s work often spans both patent and trade secret protection, particularly for clients with proprietary processes, data, or formulations.

Ray's practice is transactional. His work includes helping companies evaluate and protect their confidential know-how and trade secrets during diligence and commercial transactions. He has led hundreds of due diligence projects and prepared all forms of IP agreements and opinions. He applies his deep understanding of the life and materials sciences in a diverse range of industries such as pharmaceuticals, biotechnology, energy, manufacturing, computer hardware, water and air purification, and specialty plastics and chemicals. Ray's experience in pharmaceuticals and biotechnology extends to disciplines such as medicinal chemistry, genetics, nutraceuticals, proteomics, nanotechnology and tissue engineering.

Areas of Focus
Life SciencesIntellectual PropertyLife Sciences Intellectual PropertyPatent Development and StrategyTrade Secrets

Bar admissions
Ohio
Pennsylvania
United States Patent and Trademark Office

Courts
United States Court of Appeals for the Federal Circuit

EXPERIENCE

Counseled clients in creating regulatory exclusivity strategies that allowed for approval of numerous products without composition of matter patents or, in some cases, without Orange Book-listed patents
Represented a clinical-stage biopharmaceutical company in creating a pathway for patent and regulatory exclusivity for dermatological products
Successfully represented clients in transition from private to public as well as transition from clinical stage to marketing stage for pharmaceutical and biological products
Established a comprehensive trade secret program at a publicly listed battery company which became key evidence in helping dismiss a misappropriation claim by a key competitor.
Represented a company in creating patent and regulatory exclusivity for a topical cream
Successfully extended the exclusivity rights of a publicly traded biotechnology company’s patent portfolio beyond its natural life, with its patent portfolio extension valued in excess of US$500 million
Counseled a global healthcare company in its more than US$1 billion equity investment.
Represented a publicly traded company that manufactures and markets products that remove contaminants and odors from liquids and gases, and helped implement measures to protect proprietary manufacturing methods and trade secrets
Successfully navigated the ITC on behalf of a chemical manufacturing company in defense of patent infringement allegations

Awards

Chambers USA

Band 4, Pennsylvania Intellectual Property, (2025)
The Legal 500 United States

Recommended, Patents: Licensing (2023 – 2025)
Recommended, Patents: Prosecution (including re-examination and post-grant proceedings) (2023)

Additional Awards
Acritas Star, Acritas (2018 – 2021)
Patent 1000, International Asset Management (2014&nbs...

Education
J.D., Case Western Reserve University School of Law
M.A., Princeton University
B.S., University of Akron